Karen Tornøe

Liraglutide and Renal Outcomes in Type 2 Diabetes

Johannes F.E. Mann, David D. Ørsted, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial

Ketan Dhatariya, Stephen C. Bain, John B. Buse et al. · Diabetes Care · 2018 · 123 citations · Full text

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial

Andrew Ahmann, Helena W. Rodbard, Julio Rosenstock et al. · Diabetes Obesity and Metabolism · 2015 · 98 citations · Full text

Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Insulin and Glucagon Secretion in Humans*

Karin Filipsson, Karen Tornøe, Jens J. Holst et al. · The Journal of Clinical Endocrinology & Metabolism · 1997 · 88 citations · Full text

A prospective, claims‐based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs

Donnie Funch, Helge Gydesen, Karen Tornøe et al. · Diabetes Obesity and Metabolism · 2013 · 79 citations · Full text